Lotus Eye Hospital and Institute — 360° view

Lotus Eye Hospital and Institute, a company in the Hospital industry, reported revenue of ₹18 crore and net profit of ₹0.44 crore for the September 2026 quarter.

Lotus Eye Hospital and Institute (NSE: LOTUSEYE) closed at ₹101.12 on 20 Nov 2026, down 4.0% over the past year. Its market capitalisation is ₹210 crore and it trades at 477.9 times earnings.

Share price
₹101.12 (20 Nov 2026)
Market cap
₹210 Cr (20 Nov 2026)
P/E
477.92 (20 Nov 2026)
Revenue
₹18 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
1.41% (FY26)
ROE
0.13% (FY26)
Book value
₹29.4 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹147.00 / ₹97.59 (20 Nov 2026)
1-year return
-4.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: LOTUSEYE

Incorporated in 1990, Lotus Eye Hospital and Institute Ltd provides ophthalmology and other related services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.